This brand name is authorized in United States. It is also authorized in Australia, Austria, Brazil, Canada, Croatia, Ecuador, Estonia, Finland, France, Hong Kong SAR China, Ireland, Israel, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Spain, Tunisia, UK.
The drug AKYNZEO contains a combination of these active pharmaceutical ingredients (APIs):
1
|
UNII
7732P08TIR - NETUPITANT
|
|
Netupitant is a selective antagonist of human substance P/neurokinin 1 (NK1) receptors. Delayed emesis has been associated with the activation of tachykinin family neurokinin 1 (NK1) receptors (broadly distributed in the central and peripheral nervous systems) by substance P. As shown in in vitro and in vivo studies, netupitant inhibits substance P mediated responses. |
|
2
|
UNII
23310D4I19 - PALONOSETRON HYDROCHLORIDE
|
|
Palonosetron is a selective high-affinity receptor antagonist of the 5HT3 receptor. |
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| A04AA55 | A Alimentary tract and metabolism → A04 Antiemetics and antinauseants → A04A Antiemetics and antinauseants → A04AA Serotonin (5HT3) antagonists | |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| AU | Pharmaceutical Benefits Scheme | 10714X, 10731T |
| BR | Câmara de Regulação do Mercado de Medicamentos | 556718050001902 |
| CA | Health Products and Food Branch | 02468735 |
| EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | 4768-MEE-0719 |
| EE | Ravimiamet | 1686809, 1780129, 1814172, 1865235 |
| ES | Centro de información online de medicamentos de la AEMPS | 1151001001 |
| FI | Lääkealan turvallisuus- ja kehittämiskeskus | 376235 |
| FR | Base de données publique des médicaments | 67693946 |
| GB | Medicines & Healthcare Products Regulatory Agency | 307909 |
| HK | Department of Health Drug Office | 65260 |
| IL | מִשְׂרַד הַבְּרִיאוּת | 7798, 8966 |
| LT | Valstybinė vaistų kontrolės tarnyba | 1076759, 1085765, 1089568 |
| NL | Z-Index G-Standaard, PRK | 139696 |
| NZ | Medicines and Medical Devices Safety Authority | 17936 |
| PL | Rejestru Produktów Leczniczych | 100347479, 100433233 |
| RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | W62207001 |
| SG | Health Sciences Authority | 15031P |
| TN | Direction de la Pharmacie et du Médicament | 4843011 |
| US | FDA, National Drug Code | 69639-101, 69639-102, 69639-105 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.